TE
LEGN icon

Tema ETFs’s Legend Biotech LEGN Stock Holding History

Tema ETFs’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-54,543
Closed -$1.78M – 587
2025
Q3 		$1.78M Sell
54,543
-2,145
-4% -$79.2K 0.15% 178
2025
Q2 		$2.01M Buy
56,688
+4,680
+9% +$152K 0.53% 68
2025
Q1 		$1.76M Buy
52,008
+40,646
+358% +$1.46M 0.53% 66
2024
Q4 		$370K Buy
+11,362
New +$471K 0.15% 119

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Tema ETFs's LEGN Position: Q4 2025 in Review

Tema ETFs sold out of Legend Biotech (LEGN) in Q4 2025, closing a stake of 54,543 shares — an estimated $1.78M sold.

Tema ETFs first reported a position in LEGN in Q4 2024 and held it in 4 quarters. The position peaked at $2.01M in Q2 2025. 200 funds tracked by Wall St. Rank hold LEGN as of Q4 2025.

  • Tema ETFs reported no remaining Legend Biotech position as of Q4 2025 after selling out during the quarter.
  • Tema ETFs sold 54,543 Legend Biotech shares in Q4 2025, an estimated $1.78M.
  • Tema ETFs first reported a position in Legend Biotech in Q4 2024 and held it in 4 quarters.
  • Tema ETFs's Legend Biotech position peaked at $2.01M in Q2 2025.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2025.

Based on Tema ETFs's 13F filing for Q4 2025, filed 16 Jan 2026.